Career history of Kenneth Bartizal
Former positions of Kenneth Bartizal
| Companies | Position | Start | End |
|---|---|---|---|
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2007-06-03 | - |
| MERCK & CO., INC. | Director/Board Member | 2006-12-31 | 2007-03-31 |
| Corporate Officer/Principal | 1987-04-30 | 2007-03-31 | |
| PFIZER, INC. | Corporate Officer/Principal | 1987-12-31 | 1987-12-31 |
| Kirksville College of Osteopathic Medicine, Inc. | Corporate Officer/Principal | 1982-12-31 | - |
| Truman State University | Corporate Officer/Principal | 1982-12-31 | - |
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 2014-06-30 | - |
Training of Kenneth Bartizal
| University of Notre Dame | Doctorate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 6 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Kenneth Bartizal
- Experience
